A look at the weighted underlying holdings of the Invesco Pharmaceuticals ETF (PJP) shows an impressive 13.0% of holdings on a weighted basis have experienced insider buying within the past six ...

Researchers conducted a case-control study to assess the risk factors associated with PJP infection despite prophylaxis in a cohort of patients with AIID from South Korea. They included 1294 ...

Papa John's International, Inc. (NASDAQ: PZZA) (“Papa Johns®”) today announced an expanded partnership with PJP Investments Group (“PJP”), one of Papa Johns longest-tenured ...

Launched on 06/23/2005, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.